5/19/17 16:42 | 5/19/17 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | NJ | O | P,Chief | P | 20 | 79.69 | 25 | 0 | 36 | 1 | D | 59 | 138 | 17 | 32 | 15 | 7 | 8 | 7 | | | | | | |
5/16/17 17:37 | 5/16/17 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | NJ | O | P,Chief | P | 16 | 82.24 | 25 | 0 | 39 | 1 | D | 59 | 138 | 17 | 32 | 15 | 7 | 8 | 7 | | | | | | |
3/21/17 16:37 | 3/21/17 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | NJ | O | P,Chief | P | 5 | 83.98 | 21 | 0 | 14 | 1 | D | 103 | 92 | 37 | 11 | 18 | 9 | 7 | 2 | 3 | 7 | 12 | | | |
3/10/17 19:20 | 3/9/17 | EGRX | Eagle Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | NJ | O | P,Chief | P | 35 | 77.84 | 19 | 0 | New | 0 | D | 113 | 27 | 26 | -2 | 18 | 7 | 2 | 1 | 1 | 2 | 10 | | | |
12/2/16 11:40 | 12/2/16 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 46 | 0.9217 | 0 | 50 | 90 | 106 | D | -69 | -86 | -60 | -8 | 20 | 28 | -6 | -14 | 5 | -7 | -20 | -19 | | |
11/13/15 16:36 | 11/13/15 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 15 | 5.00 | 1 | 3 | 6 | 56 | D | 46 | 80 | 25 | -23 | 33 | 21 | 14 | -7 | 0 | 4 | -15 | -59 | -63 | -91 |
8/11/15 16:01 | 8/11/15 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 23 | 6.54 | 3 | 4 | 7 | 53 | D | 10 | 90 | 72 | 81 | 28 | 9 | 1 | -14 | 12 | 5 | -9 | -12 | -65 | -80 |
5/13/15 16:15 | 5/13/15 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 71 | 4.30 | 0 | 17 | 51 | 49 | D | -24 | 13 | 30 | -8 | -21 | -11 | 3 | 3 | -2 | -3 | 44 | 62 | 37 | -55 |
12/15/14 16:10 | 12/12/14 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 13 | 2.52 | 0 | 5 | 18 | 33 | D | -33 | -34 | -40 | -6 | -10 | -4 | -1 | 3 | 1 | 13 | 65 | 113 | 138 | 86 |
11/21/14 16:04 | 11/20/14 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CB,CEO | P | 13 | 2.54 | 0 | 5 | 22 | 28 | D | -46 | -30 | -10 | -16 | -10 | -9 | -6 | -4 | 0 | 3 | -3 | 74 | 51 | 110 |
6/6/14 09:21 | 6/5/14 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CEO | P | 37 | 2.95 | 0 | 13 | 125 | 23 | D | -58 | -48 | -30 | -48 | -31 | -1 | 1 | -1 | 14 | 28 | 32 | 8 | -12 | 93 |
11/21/13 16:40 | 11/21/13 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pernock David | PA | DO | CEO | P | 37 | 3.69 | 0 | 10 | New | 10 | D | -69 | -24 | -25 | -29 | -5 | -2 | -2 | 6 | 9 | 7 | 5 | 40 | -29 | -36 |